Viewing Study NCT03728335


Ignite Creation Date: 2025-12-24 @ 10:20 PM
Ignite Modification Date: 2026-02-21 @ 10:45 PM
Study NCT ID: NCT03728335
Status: RECRUITING
Last Update Posted: 2025-03-04
First Post: 2018-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module